Primate model unlocks clues to long-COVID’s impact on blood sugar, hints at vaccine benefits

The study uses a non-human primate model to explore the link between long-COVID and disruptions in glucose metabolism, finding a positive correlation. Vaccination appeared to improve glycemic control, suggesting a possible role in managing long-COVID symptoms.

Bristol Myers reinforces neuroscience deals; Iovance prices $150M public offering

Bristol Myers Squibb, a big pharma hardly synonymous with neuroscience drugs, is beefing up its work with two European biotechs in Alzheimer’s and undisclosed neurodegenerative

July 12, 2023

To detect breast cancer sooner, an MIT professor designs an ultrasound bra

Canan Dagdeviren has dedicated her career to creating tools that can capture data from every nook and cranny of the human body. An electrode that

July 28, 2023

Novel Antiviral Shortens COVID Illness in Outpatients, Reduces Viral Load

With oral simnotrelvir/ritonavir treatment in a vaccinated population, COVID-19 symptoms went away about 1.5 days earlier and SARS-CoV-2 viral loads fell, a Chinese placebo-controlled phase

January 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.